Clinical Trial Update: Autologous Bone Marrow Mesenchymal Stem Cells Transplantation Via Hepatic Artery in Patients With Liver Cirrhosis [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating autologous bone marrow mesenchymal stem cell transplantation via the hepatic artery in patients with l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• Autologous bone marrow mesenchymal stem cells transplantation via hepatic artery (bone marrow-derived mesenchymal stem cells)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Cirrhosis | Phase 2 | Status: UNKNOWN